Comments
Loading...
Cardio Diagnostics Hldgs (CDIO) Forecast
NewsEarningsCardio Diagnostics Hldgs (CDIO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCardio Diagnostics Hldgs (NASDAQ:CDIO) Stock Quotes, Forecast and News Summary
Cardio Diagnostics Hldgs Stock (NASDAQ: CDIO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cardio Diagnostics Hldgs (CDIO) stock?
You can purchase shares of Cardio Diagnostics Hldgs (NASDAQ:CDIO) through any online brokerage.
Who are Cardio Diagnostics Hldgs (CDIO) competitors?
Other companies in Cardio Diagnostics Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN) and T2 Biosystems (NASDAQ:TTOO).
What is the forecast, or price target, for Cardio Diagnostics Hldgs (CDIO) stock?
Cardio Diagnostics Hldgs has a consensus price target of $5.00.
What is the current price for Cardio Diagnostics Hldgs (CDIO)?
The stock price for Cardio Diagnostics Hldgs (NASDAQ: CDIO) is $0.42 last updated November 12, 2024 at 9:27 AM EST.
Does Cardio Diagnostics Hldgs (CDIO) pay a dividend?
There are no upcoming dividends for Cardio Diagnostics Hldgs.
When is Cardio Diagnostics Hldgs (NASDAQ:CDIO) reporting earnings?
Cardio Diagnostics Hldgs’s Q3 earnings are confirmed for Tuesday, November 26, 2024.
Is Cardio Diagnostics Hldgs (CDIO) going to split?
There is no upcoming split for Cardio Diagnostics Hldgs.
What sector and industry does Cardio Diagnostics Hldgs (CDIO) operate in?
Cardio Diagnostics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.